Thomas Shrader has given his Buy rating due to a combination of factors surrounding COMPASS Pathways’ progression and strategy in the mental health therapy markets. The rollout of COMP360, COMPASS ...

Psyence Biomedical (Nasdaq: PBM) plans to acquire Clairvoyant Therapeutics, a Canadian developer of psilocybin-based ...

Massachusetts voters could legalize psychedelics and create a regulated-access model for treating mental health conditions.

Millions of Americans struggling with depression could benefit from the active ingredient in magic mushrooms, new research suggests. However, approval of such treatments will depend on the U.S ...

Magic mushrooms are rising in popularity, but not in the way you might think – they’re coming for your beauty stash. Almost ...

Psychedelics are often associated with the counterculture of the 1960s, embraced by hippies as a way to "turn on, tune in, ...

Over 5 Million Americans Could Benefit If Psilocybin Approved for Depression: Study By Ernie Mundell HealthDay Reporter FRIDAY, Sept. 13, 2024 (HealthDay News) -- Over 5 million Americans could ...

Magic mushrooms are often consumed for recreational purposes as people lose their senses of space and time. Stuart Nemtim laughs after he accidentally consumed some mushroom chocolate and began ...

The market for mushroom chocolate in 2024 is now more varied and vibrant than ever before. Whether you've been using them for ...

In support of the state’s ethical and scientific exploration of psilocybin, we are dedicating part of our production to the creation of Psilocybe Liquid Culture. This research-grade product is ...

Clairvoyant currently executing a fully randomized multi-country Phase IIb clinical trial evaluating a synthetic psilocybin candidate as a potential therapeutic for Alcohol Use Disorder (AUD ...